XTNT Xtant Medical Holdings Inc

Xtant Medical Holdings Inc develops, manufactures & markets biologics products to domestic and international markets. Its products are used in treatment of spinal disease, tissue grafts for orthopedic disorders and foot and ankle surgeries.

$0.59  -0.03 (-4.54%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  03/07/2011
Outstanding shares:  108,659,388
Average volume:  24,188
Market cap:   $66,727,730
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -9.33
PB ratio:   1.80
PS ratio:   1.25
Return on equity:   -24.02%
Net income %:   -12.63%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy